Back to BlogDrug Safety

    Depo-Provera and Brain Tumors: What the Latest Research Shows

    January 8, 20256 min read
    Depo-Provera and Brain Tumors: What the Latest Research Shows

    Emerging scientific evidence has raised serious concerns about the safety of Depo-Provera, a widely used injectable contraceptive. Multiple studies now link prolonged use to an increased risk of meningiomas—tumors that develop on the brain's protective membranes.

    The Research

    A landmark French study published in the BMJ found that women who used high-dose progestogen medications like Depo-Provera for extended periods faced a significantly elevated risk of developing meningiomas—in some cases, more than five times higher than non-users.

    What Are Meningiomas?

    Meningiomas are tumors that form on the meninges, the protective layers surrounding the brain and spinal cord. While typically non-cancerous, they can cause serious symptoms as they grow:

    • Persistent headaches
    • Vision problems
    • Hearing loss or ringing in ears
    • Memory difficulties
    • Seizures
    • Weakness in limbs
    • Personality changes

    Did the Manufacturer Know?

    Evidence suggests that the risks associated with progestogen exposure were known for years before adequate warnings were provided. Pharmaceutical companies have a legal obligation to warn patients and healthcare providers about known risks.

    Your Legal Rights

    If you've used Depo-Provera for an extended period and developed a meningioma, you may be entitled to compensation for:

    • Medical expenses
    • Lost wages
    • Pain and suffering
    • Future medical care
    • Reduced quality of life

    Taking Action

    Time limits apply to these claims. If you've been diagnosed with a meningioma after using Depo-Provera, contact our office for a free, confidential case evaluation.

    Need Legal Help?

    If you've been affected by dangerous drugs, defective medical devices, or toxic exposure, our experienced attorneys are ready to help.

    Free Case Evaluation